Lucosky Brookman congratulates its client, Akers Biosciences, Inc. (OTC: AKER), a developer of rapid health information technologies. On December 21, 2017 the Company closed on a public offering of $6 million issuing an aggregate of (i) 15,500,000 Class A Units consis...